ResearcherGerman Cancer Research CenterActive in the last 2 years
Michael Volkmar
Matched on ORCID iD 0000-0001-5970-1053; OpenAlex author ID A5045338779. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 24
2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 2 papers · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper
Papers 5
- Enhanced mutanome analysis towards the induction of neoepitope-reactive T-cell responses for personalized immunotherapy of pancreatic cancer. Co-author DOI 10.1136/jitc-2025-011802↗
- Transcriptome-based identification of tumor-reactive and bystander CD8+ T cell receptor clonotypes in human pancreatic cancer. Co-author DOI 10.1126/scitranslmed.adh9562↗
- Deep molecular characterization linked to drug response profiling of pancreatic ductal adenocarcinoma using patient-derived organoids Co-author DOI 10.1101/2021.08.26.457743↗
- Human Retrotransposons and the Global Shutdown of Homeostatic Innate Immunity by Oncolytic Parvovirus H-1PV in Pancreatic Cancer. Co-author DOI 10.3390/v13061019↗
- Identification of a tumor-reactive T-cell repertoire in the immune infiltrate of patients with resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1080/2162402x.2016.1240859↗
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Rienk Offringa · 4 shared papers, 2016–2025 · strength 0.49
- Paper Enhanced mutanome analysis towards the induction of neoepitope-reactive T-cell responses for personalized immunotherapy… DOI 10.1136/jitc-2025-011802↗
- Paper Transcriptome-based identification of tumor-reactive and bystander CD8+ T cell receptor clonotypes in human pancreatic … DOI 10.1126/scitranslmed.adh9562↗
- Paper Deep molecular characterization linked to drug response profiling of pancreatic ductal adenocarcinoma using patient-der… DOI 10.1101/2021.08.26.457743↗
- Oliver Strobel · 4 shared papers, 2016–2025 · strength 0.49
- Paper Enhanced mutanome analysis towards the induction of neoepitope-reactive T-cell responses for personalized immunotherapy… DOI 10.1136/jitc-2025-011802↗
- Paper Transcriptome-based identification of tumor-reactive and bystander CD8+ T cell receptor clonotypes in human pancreatic … DOI 10.1126/scitranslmed.adh9562↗
- Paper Deep molecular characterization linked to drug response profiling of pancreatic ductal adenocarcinoma using patient-der… DOI 10.1101/2021.08.26.457743↗
- Isabel C. Poschke · 3 shared papers, 2016–2025 · strength 0.40
- Paper Enhanced mutanome analysis towards the induction of neoepitope-reactive T-cell responses for personalized immunotherapy… DOI 10.1136/jitc-2025-011802↗
- Paper Transcriptome-based identification of tumor-reactive and bystander CD8+ T cell receptor clonotypes in human pancreatic … DOI 10.1126/scitranslmed.adh9562↗
- Paper Identification of a tumor-reactive T-cell repertoire in the immune infiltrate of patients with resectable pancreatic du… DOI 10.1080/2162402x.2016.1240859↗
- Martin Ronald Sprick · 2 shared papers, 2016–2025 · strength 0.26
- Paper Enhanced mutanome analysis towards the induction of neoepitope-reactive T-cell responses for personalized immunotherapy… DOI 10.1136/jitc-2025-011802↗
- Paper Identification of a tumor-reactive T-cell repertoire in the immune infiltrate of patients with resectable pancreatic du… DOI 10.1080/2162402x.2016.1240859↗
- Andreas Trumpp · 2 shared papers, 2016–2025 · strength 0.26
- Paper Enhanced mutanome analysis towards the induction of neoepitope-reactive T-cell responses for personalized immunotherapy… DOI 10.1136/jitc-2025-011802↗
- Paper Identification of a tumor-reactive T-cell repertoire in the immune infiltrate of patients with resectable pancreatic du… DOI 10.1080/2162402x.2016.1240859↗
- Carl-Stephan Leonhardt · 2 shared papers, 2021–2023 · strength 0.24
- Paper Transcriptome-based identification of tumor-reactive and bystander CD8+ T cell receptor clonotypes in human pancreatic … DOI 10.1126/scitranslmed.adh9562↗
- Paper Deep molecular characterization linked to drug response profiling of pancreatic ductal adenocarcinoma using patient-der… DOI 10.1101/2021.08.26.457743↗
- Nathalia A. Giese · 2 shared papers, 2021 · strength 0.21
- Paper Human Retrotransposons and the Global Shutdown of Homeostatic Innate Immunity by Oncolytic Parvovirus H-1PV in Pancreat… DOI 10.3390/v13061019↗
- Paper Deep molecular characterization linked to drug response profiling of pancreatic ductal adenocarcinoma using patient-der… DOI 10.1101/2021.08.26.457743↗
- Miriam Schenk · 2 shared papers, 2021 · strength 0.21
- Paper Human Retrotransposons and the Global Shutdown of Homeostatic Innate Immunity by Oncolytic Parvovirus H-1PV in Pancreat… DOI 10.3390/v13061019↗
- Paper Deep molecular characterization linked to drug response profiling of pancreatic ductal adenocarcinoma using patient-der… DOI 10.1101/2021.08.26.457743↗
- Zibo Meng · 1 shared paper, 2023 · strength 0.14
- Heshui Wu · 1 shared paper, 2023 · strength 0.14
- Markus Wolfgang Büchler · 2 shared papers, 2016–2021 · strength 0.14
- Paper Deep molecular characterization linked to drug response profiling of pancreatic ductal adenocarcinoma using patient-der… DOI 10.1101/2021.08.26.457743↗
- Paper Identification of a tumor-reactive T-cell repertoire in the immune infiltrate of patients with resectable pancreatic du… DOI 10.1080/2162402x.2016.1240859↗
- Svitlana P. Grekova · 1 shared paper, 2021 · strength 0.12
- M. Neulinger · 1 shared paper, 2021 · strength 0.12
- Elisa Espinet · 1 shared paper, 2021 · strength 0.12
- Solange Le Blanc · 1 shared paper, 2021 · strength 0.10
- Sebastian Schuth · 1 shared paper, 2021 · strength 0.10
- Anna‐Katharina König · 1 shared paper, 2021 · strength 0.10
- Christian Conrad · 1 shared paper, 2021 · strength 0.10
- Matthias M. Gaida · 1 shared paper, 2021 · strength 0.10
- Thomas P. Hank · 1 shared paper, 2016 · strength 0.04
- Thilo Hackert · 1 shared paper, 2016 · strength 0.04
- Niels Halama · 1 shared paper, 2016 · strength 0.04
- Uğur Şahin · 1 shared paper, 2016 · strength 0.04
- Hanno Glimm · 1 shared paper, 2016 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.